✦ LIBER ✦
Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase
✍ Scribed by Yasunobu Nagata; Shiomi Fukuda; Takeshi Kobayashi; Takuya Yamashita; Kazuteru Ohashi; Hisashi Sakamaki; Hideki Akiyama
- Book ID
- 107618978
- Publisher
- Carden Jennings Publishing
- Year
- 2010
- Tongue
- English
- Weight
- 207 KB
- Volume
- 91
- Category
- Article
- ISSN
- 0925-5710
No coin nor oath required. For personal study only.